All Posts Tagged With: "LH"

(LIFE) MedTech Industry Stock Update – May 2013 – Zacks Analyst Interviews

As expected, MedTech mergers and acquisitions (M&A) are heating up in 2013. Finally, the much-hyped takeover battle for Life Technologies Corporation (LIFE) came to an end last month with Thermo Fisher Scientific...

15May2013 | | Comments Off | Continued

(JNJ) MedTech Industry Stock Outlook – January 2013 – Zacks Analyst Interviews

We are in the midst of the fourth quarter earnings season and it is once again time to review the players in the worldwide medical devices market. The US still holds the leading position with almost one-third of the market share. However, emerging economies like Brazil, Russia, India and China –...

31Jan2013 | | Comments Off | Continued

(DGX) Quest Diagnostics Remains Neutral

We recently reiterated our Neutral recommendation on Quest Diagnostics (DGX), the leading providers of commercial laboratory services in North America, with a target price of $61.00. The company...

4Dec2012 | | Comments Off | Continued

(DGX) Quest Diagnostics Disappoints in Third Quarter – Guides Low

Leading diagnostic testing company Quest Diagnostics (DGX) reported earnings per share (EPS) of $1.01 in the third quarter of 2012, down considerably from $1.08 in the year-ago period. However, after taking into account certain charges...

29Oct2012 | | Comments Off | Continued

(DGX) Quest Diagnostics’ Simplexa Passes FDA Test

Quest Diagnostics (DGX), a prominent player in the field of diagnostic testing, recently received the U.S. Food and Drug Administration’s (“FDA”) 510(k) clearance for its Simplexa Flu A/B & RSV Direct test, which was developed...

23Oct2012 | | Comments Off | Continued

(QGEN) Qiagen’s Point of Need in China

Molecular diagnostics solutions provider, Qiagen (QGEN) continued to expand its presence in China with the recent point-of-need diagnostics deal with a Beijing-based medical device company Lepu Medical Technology. The contract will...

8Oct2012 | | Comments Off | Continued

(LH) Laboratory Corporation of America Holdings Prices Senior Notes

Laboratory Corporation of America Holdings (LH), has priced its senior notes to be used primarily to repay certain amounts outstanding under its existing credit facility (announced in December, 2011), for an aggregate purchase price...

30Aug2012 | | Comments Off | Continued

(LH) Laboratory Corporation of America Holdings Earnings Scorecard

Laboratory Corporation of America Holdings’ (LH) disappointing second quarter 2012 results, released on July 19, prompted analysts to slash their estimates for the forthcoming periods, pricing in the challenges currently at play in...

31Jul2012 | | Comments Off | Continued

(LH) Laboratory Corporation of America Holdings Earnings Preview

Laboratory Corporation of America Holdings (LH) is scheduled to release its second quarter fiscal 2012 earnings on Thursday, July 19, 2012, before the market opens. The company is expected to report earnings per share (EPS) of $1.78...

23Jul2012 | | Comments Off | Continued

(QGEN) Qiagen’s KRAS Test Earns U.S. Food and Drug Administration Nod

Molecular diagnostics solutions provider, Qiagen (QGEN) recently got the nod of the U.S. Food and Drug Administration (“FDA”) to market the therascreen KRAS RGQ PCR Kit (therascreen KRAS test), which helps in determining the responsiveness...

9Jul2012 | | Comments Off | Continued

(QGEN) Qiagen Expands with New Deals

In an attempt to expand its companion diagnostic portfolio for several types of new anti-cancer drugs, Qiagen (QGEN) recently entered into two different agreements with US biotech companies, namely Insight Genetics, Inc. and Personal...

13Jan2012 | | 0 comments | Continued

(LH) Laboratory Corporation of America Holdings-Orchid Deal Evinces FTC Nod

Laboratory Corporation of America Holdings (LH) received the much awaited nod from the US Federal Trade Commission (FTC) for the proposed acquisition of Orchid Cellmark (ORCH)....

9Dec2011 | | 0 comments | Continued

(LH) Laboratory Corporation of America Holdings Extends Orchid Bid Again

Laboratory Corporation of America Holdings (LH) has once again extended the tender offer for Orchid Cellmark (ORCH) until December 9, 2011. The company had earlier...

7Dec2011 | | 0 comments | Continued

(LH) Laboratory Corporation of America Holdings Earnings Scorecard

The announcement of Laboratory Corporation of America Holdings’ (LH) third quarter fiscal 2011 results, as on October 20, 2011, has led analysts to revise their estimates lower for the fourth quarter and fiscal 2011. Third...

3Nov2011 | | 0 comments | Continued

(AAPL) A Busy Week Ahead – Earnings Preview

Earnings Preview 10/14/11 While the earnings season kicked off this past week, only 38 firms reported. The game really gets under way next week, when we will get reports from 336 firms, including 99 members of the S&P 500. Thus, by the end of the week we will have a very good idea...

17Oct2011 | | 0 comments | Continued

(LH) Laboratory Corporation of America Holdings-UnitedHealth Extend Pact

Last week, Laboratory Corporation of America Holdings (LH) announced that it has extended its agreement with UnitedHealthcare Insurance Company, an affiliate of UnitedHealth Group (UNH)....

15Sep2011 | | 0 comments | Continued

(AAPL) 2011 Second Quarter Earnings Preview – Detailed

Earnings Preview 7/15/11 Second quarter earnings season is now under way, but things really start to move into high gear next week. There will be 348 firms reporting, and 108 of those are in the S&P 500. By next...

18Jul2011 | | 0 comments | Continued

(DGX) Quest Diagnostics Seeks Regular Colon Test

Leading diagnostics player Quest Diagnostics (DGX) is dissatisfied with the outcome of a nationwide study that it had carried out along with the Colon Cancer Alliance. The data demonstrated that one in three of men and women aged 60-70...

29Jun2011 | | 0 comments | Continued

(DGX) Quest Diagnostics Launches Gazelle on Android

Quest Diagnostics (DGX),a leading player in the diagnostic testing market, recently launched a new version of its mobile health platform, Gazelle. The company claims that this latest version will work in sync with Google’s...

23Jun2011 | | 0 comments | Continued

(LH) Laboratory Corporation of America Holdings Extends Orchid Tender Offer

Laboratory Corporation of America Holdings (LH) has decided to extend the tender offer for Orchid Cellmark (ORCH) till July 15, 2011. Earlier, in May 2011, the company...

19Jun2011 | | 0 comments | Continued

(DGX) Quest Diagnostics Expedites Celera Acquisition

Leading diagnostics player, Quest Diagnostics (DGX) took a step forward toward the proposed acquisition of Celera Corporation (CRA). The company recently announced...

15Apr2011 | | 0 comments | Continued

(GENZ) Genzyme Corporation is in Deal for Sale of Diagnostic Business

Genzyme Corporation (GENZ) recently announced that it has entered into an agreement with Japanese company, Sekisui Chemical Co., Ltd. for the sale of its diagnostic products business. Sekisui will acquire Genzyme’s diagnostic products...

6Dec2010 | | 0 comments | Continued

(LH) LabCorp First Quarter 2010 Earnings Scorecard

First Quarter Highlights On April 21, LabCorp (LH) reported first quarter fiscal 2010 earnings per share (EPS) of $1.25 compared with earnings of $1.22 in the year-ago period. However, after considering restructuring...

23May2010 | | 0 comments | Continued

(LH) Laboratory Corporation of America Holdings Misses by a Penny

Laboratory Corporation of America Holdings (LH) reported first quarter fiscal 2010 earnings per share (EPS) of $1.25 compared to earnings of $1.22 reported in the year-ago period. However, after considering restructuring and other special...

22Apr2010 | | 0 comments | Continued